| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |